跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-NEBIVOLOL nebivolol (as hydrochloride) 1.25 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-NEBIVOLOL nebivolol (as hydrochloride) 1.25 mg tablet blister pack
Approved
STANDARD
APO-NEBIVOLOL nebivolol (as hydrochloride) 1.25 mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
91f07024734bb9fa
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
91f07024734bb9fa
Product Name
APO-NEBIVOLOL nebivolol (as hydrochloride) 1.25 mg tablet blister pack
Artg Id
281799
Artg Name
APO-NEBIVOLOL nebivolol (as hydrochloride) 1.25 mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2018-02-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fd0e5dc4c4d797a99228749e23f3dd14.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/bff4ff0501c401b01f4b043e409697ef.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
91f07024734bb9fa
Type
Standard
Back to TGA Approvals